CARL · NASDAQ
Carlsmed (CARL) Stock Price & Fundamentals
Carlsmed (CARL) closed at $488.77 on Oct 9, 2026, up 0.65% from the previous close of $485.61.
Share price, past year
1Y +28.65%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $488.77 |
| Sep 30, 2026 | $491.15 |
| Aug 31, 2026 | $487.78 |
| Jul 31, 2026 | $506.37 |
| Jun 30, 2026 | $475.45 |
| May 29, 2026 | $450.73 |
| Apr 30, 2026 | $422.92 |
| Mar 31, 2026 | $405.75 |
| Feb 27, 2026 | $366.90 |
| Jan 30, 2026 | $402.85 |
| Dec 31, 2025 | $404.44 |
| Nov 28, 2025 | $402.26 |
| Oct 31, 2025 | $387.94 |
Key statistics
- Market cap
- $13.31B
- P/E (TTM)
- 4,443.4
- EPS (TTM)
- $0.11
- Revenue (TTM)
- $63.30M
- Net income (TTM)
- −$36.35M
- Shares outstanding
- 27.2M
- Dividend yield
- —
- 52-week range
- $366.86 – $512.23
Carlsmed's market cap is $13.31B, based on a share price of $488.77 and 27.2M shares outstanding as of Jun 30, 2026.
Financials
Carlsmed reported revenue of $50.51M for fiscal 2025, up 85.94% from fiscal 2024.
Carlsmed reported a net loss of $29.63M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $50.51M | +85.9% | −$29.63M | −58.7% | −$2.12 | −$29.62M |
| FY2024ended Dec 31, 2024 | $27.17M | — | −$24.26M | −89.3% | −$6.11 | −$25.65M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $18.94M | −$10.51M | −$0.39 |
| Q1 FY2026ended Mar 31, 2026 | $16.12M | −$8.70M | −$0.32 |
| Q4 FY2025ended Dec 31, 2025 | $15.17M | −$8.61M | $1.22 |
| Q3 FY2025ended Sep 30, 2025 | $13.07M | −$8.53M | −$0.40 |
| Q2 FY2025ended Jun 30, 2025 | $12.08M | −$6.77M | −$1.47 |
| Q1 FY2025ended Mar 31, 2025 | $10.19M | −$5.73M | −$1.47 |
| Q3 FY2024ended Sep 30, 2024 | $6.59M | −$7.81M | −$2.06 |
| Q2 FY2024ended Jun 30, 2024 | $6.08M | — | −$1.55 |
Company profile
- Name
- Carlsmed, Inc.
- Ticker
- CARL
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 1800 Aston Avenue, Suite 100, Carlsbad, CA 92008
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001794546
Recent SEC filings
- Sep 30, 2026
- Sep 8, 2026
- Aug 5, 2026
- Aug 5, 2026
- Jun 3, 2026
- May 5, 2026
- May 5, 2026
- Feb 25, 2026
Frequently asked questions
What is Carlsmed's stock price?
Carlsmed (CARL) closed at $488.77 on Oct 9, 2026, up 0.65% from the previous close of $485.61.
What is Carlsmed's market cap?
Carlsmed's market cap is $13.31B, based on a share price of $488.77 and 27.2M shares outstanding as of Jun 30, 2026.
How much revenue does Carlsmed make?
Carlsmed reported revenue of $50.51M for fiscal 2025, up 85.94% from fiscal 2024.
What is CARL's P/E ratio?
Carlsmed's price-to-earnings ratio is 4,443.4, based on trailing twelve-month diluted EPS of $0.11.
Does Carlsmed pay a dividend?
Carlsmed's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Carlsmed, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures